"go and look at the costs incurred by MSB when they did a FDA P2, yourself"
I looked and the costs incurred by MSB for a FDA P2 trial in gvhd were zero. Nada. Lock it in, little lordy.
"How did they arrive at the purchase price of the US$100M deal?"
Probably out of thin air. That seems to be the MSB corporate strategy, after all - just come up with something out of thin air and pray you can manipulate a group of scientists that your manufacturing process doesn't leave patients a victim of excessive heterogeneity.
It was clearly $100M too much, given how many bums you've managed to jab in the commercial market well-over a decade on. Sounds like a classic SI own-goal.
My oh my you are entertaining, plodge.
CYP Price at posting:
19.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)